Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L7a pseudogene 21 (RPL7AP21)
- Target
- RPL7AP21
- Molecular classification
- Pseudogene, Processed pseudogene
01
Overview
RPL7AP21 (ribosomal protein L7a pseudogene 21) is a processed pseudogene found in the human genome, annotated in gene databases as a non-functional copy of the protein-coding RPL7A gene, which encodes ribosomal protein L7a[3][4][2][6]. RPL7AP21 does not produce a functional protein, and there is no current evidence of biological or disease relevance or of druggability. It is one of many ribosomal protein pseudogenes, and unlike the parental RPL7A gene, it has no recognized cellular function or role in disease, nor is it considered a therapeutic target[3][5].
- Other names
- RPL7AP21RPL7A_4_120RPL7A pseudogene 21
02
Biological functions
Typically none (most pseudogenes are non-functional and do not encode a protein, but some pseudogene transcripts may regulate parental gene expression via RNA-based mechanisms in rare cases; no such role is currently reported for RPL7AP21.)
03
Disease associations
None known specifically for RPL7AP21General note: Some pseudogenes have been implicated in cancer or other disease via RNA-mediated gene regulation, but there is no evidence for RPL7AP21.
Beyond the preview
Go deeper on Ribosomal protein L7a pseudogene 21 (RPL7AP21).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L7a pseudogene 21 (RPL7AP21).